Empagliflozin vs Methotrexate

Empagliflozin vs Methotrexate: Overview

This comparison examines the pharmacological differences between Empagliflozin and Methotrexate.

Mechanism of Action

Empagliflozin: Selective SGLT2 inhibitor reducing renal glucose reabsorption.

Methotrexate: Dihydrofolate reductase inhibitor.

Pharmacokinetics

Half-life: Empagliflozin — 12.4 hours; Methotrexate — 3-10 hours.

Chemical Properties

Molecular Formula: Empagliflozin — C23H27ClO7; Methotrexate — C20H22N8O5.

Molecular Weight: Empagliflozin — 450.9100 g/mol; Methotrexate — 454.4400 g/mol.

Type: Empagliflozin — Small molecule; Methotrexate — Small molecule.